Canadian Nano Pharmaceutical Technology (CNANO)
Vancouver, CA · 1 known investors
Find your way into Canadian Nano Pharmaceutical Technology (CNANO)
Sign up to see every warm intro you have to Canadian Nano Pharmaceutical Technology (CNANO)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Canadian Nano Pharmaceutical Technology (CNANO) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
novoLUX develops science-based skincare using LNP3, a patented triple-layer lipid nanoparticle technology that delivers peptides, exosomes, and PDRN with sustained release. The products target specific skin concerns such as acne-prone skin, post-procedure repair, dryness, hyperpigmentation, fine lines, and radiance.
Investors · 1
Frequently asked questions
- What does Canadian Nano Pharmaceutical Technology (CNANO) do?
- novoLUX develops science-based skincare using LNP3, a patented triple-layer lipid nanoparticle technology that delivers peptides, exosomes, and PDRN with sustained release. The products target specific skin concerns such as acne-prone skin, post-procedure repair, dryness, hyperpigmentation, fine lines, and radiance.
- Who are Canadian Nano Pharmaceutical Technology (CNANO)'s investors?
- Canadian Nano Pharmaceutical Technology (CNANO)'s investors include Innovation UBC.
- Where is Canadian Nano Pharmaceutical Technology (CNANO) headquartered?
- Canadian Nano Pharmaceutical Technology (CNANO) is headquartered in Vancouver, CA.

